CD8A and neoplasm: The purpose of cancer immunotherapy is to stimulate cytotoxic T lymphocytes/CD8+ T cells against tumour associated proteins/receptors and, help the initiation of tumour specific T cells in lymphoid organs to achieve efficient and long-lasting anti-tumour immunity [125].